FDA Approved: TROGARZO — Supplemental Application (Theratechnologies Inc.)

View source ↗

Summary

The FDA approved Theratechnologies' supplemental application for TROGARZO (ibalizumab), resulting in updated labeling and/or expanded use for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Trogarzo (ibalizumab)

Snippet

SUPPL AP for TROGARZO (IBALIZUMAB)